MedPath

The effect of magnesium sulfate on post-cesarean pain control

Phase 3
Conditions
cesarean section.
Complication of labor and delivery
O75.9
Registration Number
IRCT20190123042473N1
Lead Sponsor
Birjand University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
42
Inclusion Criteria

Women without history of bleeding after surgery.
Women without allergy to Amide anesthetics.
Women without history of heart, liver and renal diseases.
Women without history of taking psychedelic drugs.
The women with the age of 15 - 45 years.
The women without history of smoking.
The women without history of coagulation diseases.
The women without history of infectious diseases.

Exclusion Criteria

Having neuro-muscular disease
Use of opioids or painkillers during 3 days before the study
Severe obesity (BMI = 35-34)
Consumption of calcium channel blockers

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain. Timepoint: at 1, 2, 3, 4, 8, 12 postoperative hours. Method of measurement: Verbal Analogue Scale method.;Blood pressure. Timepoint: at 1, 2, 3, 4, 8, 12 postoperative hours. Method of measurement: Mercury sphygmomanometer.;Hear rate. Timepoint: at 1, 2, 3, 4, 8, 12 postoperative hours. Method of measurement: heart-rate monitors.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath